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Predictive Model for Length of Hospital Stay
of Patients Surviving Surgery for Perforated
Peptic Ulcer
Chin-Hsien Li,1 Ming-Jong Bair,1 Wen-Hsiung Chang,2 Shou-Chuan Shih,2
Shee-Chan Lin,2 Ching-Ying Yeh3*
Background/Purpose: Many studies have assessed the major risk factors for mortality or morbidity in 
surgical patients with perforated peptic ulcer (PPU). The aim of our study was to focus on survivors and to
investigate the predictive factors for length of hospital stay (LOHS) for surgical patients.
Methods: The medical records of 195 patients who survived surgery were reviewed retrospectively. The 
following factors were analyzed: patient profile, associated medical illnesses, diagnostic methods, fever,
preoperative shock, clinical data from the emergency room, delays in surgery, sites of perforation, opera-
tive methods, positive ascites culture and species of microorganism, postoperative infection, and non-
infective postoperative complications.
Results: Univariate analysis showed that the following factors were significantly related to longer LOHS:
age > 65 years, liver cirrhosis, diabetes mellitus, history of peptic ulcer disease, number of comorbid dis-
eases, preoperative shock, creatinine > 1.5 mg/dL, surgical delay of > 12 hours, and all postoperative fac-
tors except species of microorganisms in ascites culture. In a multivariate linear regression model, catheter
infection, pneumonia, urinary tract infection, wound infection, bacteremia, non-infective abdominal com-
plications, other infections, surgical delay of > 12 hours, and comorbidity were major factors associated
with longer LOHS.
Conclusion: A predictive model was established with nine factors that explained 71.6% of the variation 
in LOHS of patients who survived surgery for PPU. Several corrective methods based on the model can be
devised by attending physicians to shorten LOHS. [J Formos Med Assoc 2009;108(8):644–652]
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complications
Perforated peptic ulcer (PPU) is one of the compli-
cations of peptic ulcer disease that needs surgical
intervention. The overall incidence of PPU has
been shown to be unchanged or even decreased in
recent studies,1–5 and the current trend shows that
PPU has become more common in elderly patients
and in women than before.1–3 Many studies have
assessed the risk factors associated with mortality or
morbidity in the surgical treatment of PPU,5–16 but
only a few have discussed the risk factors related
to length of hospital stay (LOHS) for patients
with PPU undergoing surgical treatment.7,17
The present retrospective study was designed
to identify the risk factors associated with LOHS
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for patients who survived after surgery for PPU,
and to establish a predictive model for LOHS that
will allow attending physicians to implement
corrective action.
Patients and Methods
We retrospectively reviewed the medical records
of all patients who survived surgery for PPU
from January 1995 to December 2006. Patient
profiles and associated major medical illnesses
were recorded. The following variables were also
collected: diagnostic method, fever, preoperative
shock (systolic blood pressure < 90 mmHg), clin-
ical data from the emergency room, time from
start of symptoms to operation, site of perforation,
operative method, positive ascites culture and
species of microorganisms, postoperative infec-
tion [bacteremia, pneumonia, wound infection,
urinary tract infection (UTI), catheter infection,
and other infections], noninfective postoperative
complications (general and abdominal compli-
cations), and LOHS. The operative methods were
divided into three groups: simple closure method,
pyloroplasty with vagotomy, and any other form
of gastrectomy.
Statistical analysis
Independent t tests or one-way analysis of vari-
ance were used for univariate comparisons where
appropriate. Variables with p < 0.05 were then
entered into a multiple linear regression model.
Variables where p < 0.05 in the final model were
considered independent predictors of longer
LOHS. SPSS version 12 (SPSS Inc., Chicago, IL,
USA) for Windows was used for these analyses.
Results
One hundred and ninety-five patients with PPU
survived and were discharged from our hospital.
Their mean age (± standard deviation) was 56.9 ±
18.7 years (range, 2–86 years), and their mean
LOHS was 18.1 ± 13.8 days (range, 6–80 days).
There was no apparent regular change or differ-
ence in mean LOHS according to the time of 
patient enrolment (data not shown).
In univariate analyses, all variables were di-
vided into three categories: patient demographics,
initial clinical factors, and postoperative factors.
In patient demographic analysis (Table 1), pa-
tients aged ≥ 65 years, with liver cirrhosis, dia-
betes mellitus and a history of peptic ulcer had a
significantly longer mean LOHS than those aged
< 65 years and those without these diseases (p <
0.05). Patients with no coexisting disease had 
a significantly shorter LOHS, a decrease of > 7
days, than those with two or more major medical
illnesses (p = 0.001), but LOHS was not signifi-
cantly shorter than for those with only one major
illness. There were also no significant differences
in mean LOHS among patients with one, two, 
or more major medical illnesses. Among initial
clinical factors (Table 2), there was a statistically
significant increase of > 8 days in mean LOHS for
patients with preoperative shock, creatinine level
> 1.5 mg/dL, and a delay before surgery of > 12
hours (p < 0.05). Analysis of postoperative fac-
tors (Table 3) showed that patients with perfora-
tion in the pylorus had a significantly shorter
mean LOHS than those with perforation in the
stomach (p < 0.05). However, no significant dif-
ference was found in patients with perforation in
the duodenum. Patients who underwent pyloro-
plasty with vagotomy had a significantly shorter
LOHS than those treated with simple closure
(p < 0.05), but there was no significant difference
in patients who underwent gastrectomy. Patients
with any postoperative infection or complications,
such as positive ascites culture, wound infection,
bacteremia, pneumonia, catheter infection, UTI,
other infections, noninfective general and abdom-
inal complications, all stayed in hospital for signif-
icantly longer than those without any infection
or complications (p < 0.05).
In multivariate analyses (Table 4), all statis-
tically significant factors (p < 0.05) in the uni-
variate analysis were separated into preoperative
and postoperative factors for analytical simplifica-
tion and comparison. In model 1 (preoperative),
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Table 1. Univariate analysis of patient demographics
Number (%) Mean (d) SEM p
Personal characteristics
Sex Male 151 (77.4) 17.4 1.10 0.171
Female 44 (22.6) 20.7 2.22
Age (yr) < 65 114 (58.5) 15.5 1.16 0.002*
≥ 65 81 (41.5) 21.8 1.66
Smoking None 59 (30.3) 20.0 1.97 0.512
Occasionally 2 (1.0) 13.0 3.00
Everyday 110 (56.4) 16.8 1.27
Quit 8 (4.1) 22.8 3.10
No record 16 (8.2) 18.8 3.62
Alcohol drinking None 73 (37.4) 19.5 1.74 0.257
Socially 20 (10.3) 14.7 1.56
Everyday 81 (41.5) 16.8 1.51
Quit 5 (2.6) 27.6 8.10
No record 16 (8.2) 19.8 3.59
Betel nut chewing None 67 (34.4) 20.9 1.85 0.181
Few 6 (3.1) 21.5 9.08
Everyday 20 (10.3) 15.7 2.09
No record 102 (52.3) 16.6 1.28
Underlying diseases
Liver cirrhosis Yes 8 (4.1) 33.4 6.15 0.001*
No 187 (95.9) 17.5 0.97
Diabetes mellitus Yes 17 (8.7) 25.5 3.37 0.021*
No 178 (91.3) 17.4 1.02
COPD/asthma Yes 15 (7.7) 17.9 1.73 0.936
No 180 (92.3) 18.2 1.06
IHD/CHF Yes 15 (7.7) 23.5 2.57 0.116
No 180 (92.3) 17.7 1.05
CVD history Yes 15 (7.7) 24.4 3.33 0.068
No 180 (92.3) 17.6 1.03
PUD history Yes 65 (33.3) 21.0 1.87 0.043*
No 130 (66.7) 16.7 1.14
Hypertension Yes 34 (17.4) 21.5 2.03 0.123
No 161 (82.6) 17.4 1.11
Malignancy Yes 7 (3.6) 25.0 6.88 0.182
No 188 (96.4) 17.9 0.99
NSAID use Yes 47 (24.1) 21.3 2.28 0.069
No 148 (75.9) 17.1 1.08
Number of comorbid diseases Healthya 91 (46.7) 14.1 1.18 0.001*
1ab 56 (28.7) 20.3 2.22
2b 25 (12.8) 22.8 2.89
≥ 3b 23 (11.8) 23.7 2.22
*p < 0.05; a,baccording to statistical grouping. SEM = standard error of the mean; COPD = chronic obstructive pulmonary disease; 
IHD = ischemic heart disease; CHF = congestive heart failure; CVD = cerebrovascular disease; PUD = peptic ulcer disease; NSAID =
nonsteroidal anti-inflammatory drug.
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four variables were associated independently with
longer LOHS: preoperative shock (p < 0.001); cre-
atinine > 1.5 mg/dL (p = 0.007); comorbidity (p =
0.008); and delay before surgery > 12 hours
(p = 0.003). The adjusted R2 value of this model
was 0.329. In model 2 (postoperative), eight vari-
ables were independently associated with longer
LOHS: bacteremia (p < 0.001); pneumonia (p <
0.001); wound infection (p<0.001); catheter infec-
tion (p < 0.001); UTI (p < 0.001); other infections
(p < 0.001); noninfective general complications
(p = 0.038); and noninfective abdominal compli-
cations (p < 0.001). The adjusted R2 value of this
model was 0.703. We entered factors with p < 0.05
in model 3 into the final model, except for delay
before surgery > 12 hours (p = 0.055). In the final
model (combining preoperative and postopera-
tive factors), nine variables were independently
associated with longer LOHS: comorbidity (p =
0.030); delay before surgery >12 hours (p=0.010);
bacteremia (p < 0.001); pneumonia (p < 0.001);
wound infection (p < 0.001); catheter infection
(p < 0.001); UTI (p < 0.001); other infections (p <
0.001); and noninfective abdominal complications
(p < 0.001). The predictive equation for LOHS is
described below. The adjusted R2 value of this
equation was 0.716. Thus, the final multiple re-
gression model for LOHS of patients who survived
surgery for PPU was:
LOHS (days) = 10 + 18 × (catheter infection)
+ 14 × (pneumonia) + 12 × (UTI) + 7 × (wound
infection)+11× (noninfective abdominal com-
plications) + 11 × (bacteremia) + 10 × (other
infections) + 4 × (delay before surgery > 12
hours) + 2 × (comorbidity),
Table 2. Univariate analysis of initial clinical factors
Clinical data (from emergency room) Number (%) Mean (d) SEM p
Fever or hypothermia Yes 34 (17.4) 18.3 1.50 0.944
No 161 (82.6) 18.1 1.16
Preoperative shock Yes 11 (5.6) 38.1 5.62 0.004*
No 184 (94.4) 17.0 0.93
Diagnostic method X-ray 151 (77.4) 17.0 1.07 0.085
CT findings 25 (12.8) 22.8 2.98
Exploratory laparotomy 19 (9.7) 21.4 3.78
Amylase (U/L) Elevated 33 (16.9) 22.6 3.30 0.051
Normal 115 (59.0) 15.6 1.01
Lipase (U/L) Elevated 12 (6.2) 24.7 6.39 0.199
Normal 59 (30.3) 15.8 1.24
Anemia (g/dL) ≥ 10 164 (84.1) 17.3 1.05 0.154
< 10 29 (14.9) 21.0 2.13
WBC count (cells/mm3) < 4000 8 (4.1) 16.8 2.12 0.655
≥ 4000, ≤ 10,000 77 (39.5) 18.7 1.67
> 10,000, ≤ 12,000 34 (17.4) 15.6 1.80
> 12,000, ≤ 15,000 40 (20.5) 17.4 2.17
> 15,000 36 (18.5) 20.4 2.67
Left shifting (%) Segmented ≤ 85% 126 (64.6) 17.4 1.15 0.279
Differentiated count Segmented > 85% or band ≥ 6% 69 (35.4) 19.6 1.84
Creatinine (mg/dL) ≤ 1.5 150 (76.9) 16.6 0.94 0.020*
> 1.5 31 (15.9) 25.2 3.39
Delay before surgery (hr) > 12 31 (15.9) 30.6 3.36 < 0.001†
≤ 12 164 (84.1) 15.8 0.88
*p < 0.05; †p < 0.001. SEM = standard error of the mean; CT = computed tomography; WBC = white blood cell.
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where the value of all independent variables was
0 or 1.
Discussion
LOHS after surgical intervention is one of the mea-
surable outcomes for determining which health-
care institutions have the best quality of care for
postsurgical patients, and which operative meth-
ods have the best result (for diseases that can be
treated by surgery). LOHS also contributes sig-
nificantly to the total cost of hospitalization and
can result in a larger financial burden on patients.
The development of a predictive model for LOHS
of surgical patients, based on clinical data, may
assist with establishing risk factors that are asso-
ciated with quality of care among postsurgical
patients, and may influence the surgical outcome
of patients. Furthermore, it may promote progress
in medical care and operative methods, by im-
proving these modifiable factors. We established
a predictive model for LOHS of patients who
survived surgery for PPU, based on patient de-
mographics, and initial clinical and postopera-
tive factors. Nine risk factors in this model were
Table 3. Univariate analysis of postoperative factors
Postoperative data Number (%) Mean (d) SEM p
Site of perforation Stomachb 40 (20.5) 23.5 2.43 0.015*
Pylorusa 121 (62.1) 15.7 1.07
Duodenumab 34 (17.4) 20.6 2.87
Operative method Simple closureb 51 (26.2) 22.4 2.17 0.020*
Pyloroplasty + VTa 130 (66.7) 15.8 1.07
Gastrectomyab 14 (7.2) 24.2 4.55
Ascites culture Growth 73 (37.4) 22.4 1.99 < 0.001†
No growth 34 (17.4) 12.3 0.88
Number of species of 1 37 (19.0) 20.1 2.40 0.280
microorganisms in 2 26 (13.3) 22.7 3.61
ascites culture ≥ 3 10 (5.1) 29.8 6.50
Wound infection Yes 33 (16.9) 27.7 2.50 < 0.001†
No 162 (83.1) 16.2 1.01
Bacteremia Yes 9 (4.6) 45.2 5.82 < 0.001†
No 186 (95.4) 16.8 0.90
Pneumonia Yes 20 (10.3) 38.0 4.67 < 0.001†
No 175 (89.7) 15.9 0.81
Catheter infection Yes 13 (6.7) 43.2 6.25 0.001*
No 182 (93.3) 16.4 0.82
UTI Yes 11 (5.6) 39.8 7.59 0.013*
No 184 (94.4) 16.9 0.87
Other infections Yes 10 (5.1) 44.1 5.57 0.001*
No 185 (94.9) 16.7 0.89
General complications Yes 10 (5.1) 43.3 6.78 0.004*
(noninfective) No 185 (94.9) 16.8 0.88
Abdominal complications Yes 13 (6.7) 37.4 5.95 0.005*
(noninfective) No 182 (93.3) 16.8 0.90
*p < 0.05; †p < 0.001; a,baccording to statistical grouping. SEM = standard error of the mean; VT = vagotomy; UTI = urinary tract 
infection.
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independently associated with longer LOHS: cath-
eter infection, pneumonia, UTI, wound infection,
noninfective abdominal complications, bacter-
emia, other infections, delay before surgery > 12
hours, and comorbidity. This model explained
71.6% of the total variance of LOHS of patients
who survived surgery for PPU.
Two previous studies have concluded that delay
before surgery of > 12 hours and age > 75 years
significantly prolonged hospital stay for patients
with PPU.7,17 Both of these studies included
deaths and survivors and did not focus solely on
the latter. In previous studies, most deaths oc-
curred early after surgery.8,17 Fatal cases would
have shortened the LOHS of patients with PPU.
In order to establish the real risk factors other
than death that may have influenced LOHS, only
survivors were included in the present study. It
was found that delay before surgery (> 12 hours)
was associated significantly with longer LOHS in
model 1 (preoperative). In several other studies,
delay before surgery (> 12 hours or 24 hours)
was not only an independent adverse risk factor
for mortality,5,8,9,12,13,16 but also significantly re-
lated to postoperative death in the elderly (> 70
years).14,18 Age ≥ 65 years was an independent
predictor of mortality in three previous stud-
ies.10,12,16 In the present study, age was a statisti-
cally significant factor in univariate analysis but
not in multivariate analysis. Even when age was
Table 4. Multiple linear regression model for length of hospital stay (d)
Model 1 Model 2 Model 3 Final model
Preoperative Postoperative 
All factors All factors
factors factors
B value SE B value SE B value SE B value SE
1. Constant 10.42* 1.30 8.22† 2.87 9.77* 0.83 9.89* 0.81
2. Age ≥ 65 (yr) 2.92 1.84
3. Liver cirrhosis (yes/no) 5.24 4.49
4. Diabetes mellitus (yes/no) 2.44 3.14
5. PUD history (yes/no) −2.56 2.34
6. Comorbidity (yes/no) 6.54† 2.43 3.16† 1.15 2.43† 1.11
7. Preoperative shock (yes/no) 17.79* 3.58 3.03 2.56
8. Creatinine > 1.5 (mg/dL) 6.16† 2.26 0.58 1.61
9. Delay before surgery >12 hr 7.52† 2.49 3.09 1.60 4.09† 1.57
10. Site of perforation 2.92 1.93
11. Operative method 2.02 2.65
12. Ascites culture growth 0.74 1.22
(yes/no)
13. Bacteremia (yes/no) 12.02* 2.89 13.30* 3.15 10.50* 2.89
14. Pneumonia (yes/no) 13.84* 1.97 12.07* 2.08 14.06* 1.84
15. Wound infection (yes/no) 7.60* 1.57 6.57* 1.53 7.42* 1.51
16. Catheter infection (yes/no) 17.43* 2.59 12.55* 2.62 17.68* 2.36
17. UTI (yes/no) 13.29* 2.55 11.97* 2.42 12.30* 2.41
18. Other infections (yes/no) 10.28* 2.72 11.80* 2.78 10.03* 2.63
19. Noninfective general 5.77† 2.76 3.11 2.70
complications (yes/no)
20. Noninfective abdominal 10.33* 2.37 9.04* 2.26 11.07* 2.25
complications (yes/no)
Adjusted R2 32.9% (n = 181)* 70.3% (n = 195)* 71.5% (n = 181)* 71.6% (n = 195)*
*p < 0.001; †p < 0.05. SE = standard error; PUD = peptic ulcer disease; UTI = urinary tract infection.
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dichotomized to ≥ 75 years or < 75 years, it was
still not significantly associated with longer LOHS
in multivariate analysis (data not shown). Chou
et al8 came to a similar conclusion in their study.
They concluded that it is not age itself, but the
fact that older patients have more severe medical
problems and longer delays in treatment that 
result in higher mortality. The present study also
found that the majority of patients with more
than one coexisting disease, delay before surgery
of > 12 hours, and some postoperative infections
were > 65 years of age (data not shown). Other
previous studies have also concluded that age 
is not a significant risk factor for mortality in
multivariate logistic regression analysis.9,15
Among the other preoperative factors, the
number of comorbid diseases did not signifi-
cantly influence LOHS in model 1 (data not
shown), but comorbidity (healthy, or having at
least one coexisting major illness) significantly
prolonged LOHS. Comorbidity has been shown
to be an independent predictor of mortality 
in surgically treated PPU patients.8–10,13,15 These
previous studies have not established which co-
existing major diseases significantly influence
surgical mortality in patients with PPU. The mul-
tiple regression analysis in the present study did
not find any one major disease that influenced
LOHS. Similarly, preoperative shock, which is 
related significantly to postoperative mortality of
PPU,9,13,15,16 was significantly associated with
longer LOHS in model 1. The final factor in
model 1 that was associated significantly with
longer LOHS was creatinine > 1.5 mg/dL. One
previous study has found that preoperative serum
creatinine ≤ 1.5 mg/dL is the most powerful pre-
dictor of postoperative survival for PPU,19 al-
though many subsequent studies have included
renal disease as a comorbidity in their analysis of
mortality or morbidity in surgically treated
PPU.8,9,13,15,16,18
Among the postoperative factors, site of per-
foration and operative method have been ana-
lyzed in several studies, but there has been no
agreement as to which site of perforation is the
major risk factor for postoperative mortality, or
which operative method is the optimal treatment
for PPU.5,7–10,13–18 In the present study, these fac-
tors were not significant predictors (based on mul-
tiple regression analysis). Positive ascites culture
has been reported to be a significant variable that
is related to morbidity in one study, but it does
not independently influence morbidity in logis-
tic regression analysis.5 In the present study, pos-
itive ascites culture did not significantly prolong
LOHS in model 2. Other postoperative factors in
model 2 were infections and noninfective com-
plications, and they were all statistically signifi-
cant (p < 0.001). The other infections included
sepsis (2 cases), intra-abdominal abscess (6 cases),
and cellulitis (2 cases). The noninfective general
complications included respiratory failure (7
cases), myocardial infarction (2 cases), and deep
venous thrombosis (1 case). The noninfective
abdominal complications included pancreatitis
(2 cases), wound dehiscence (10 cases), anasto-
motic leakage (1 case), and enterocutaneous 
fistula (2 cases). In a few previous studies, post-
operative abdominal complications (dehiscence/
abscess, bleeding and stenosis), postoperative
wound infections, intra-abdominal abscess, and
septicemia were found to be significantly associ-
ated with mortality.6,13 There were some differ-
ences in the classification of complications and
infections in the present study, compared with
previous studies.8,10,13,15,16,18 To differentiate the
influence of infective and noninfective events on
LOHS, postoperative infective and noninfective
variables were used in this study, and they all 
significantly prolonged LOHS in model 2.
In the multiple linear regression analysis, the
postoperative factors were more important in
predicting longer LOHS than preoperative fac-
tors, and infective events had a more powerful
influence on LOHS than noninfective complica-
tions. Delay before surgery of > 12 hours and co-
morbidity were the only two preoperative factors
in the final model. This was probably because 
a delay in surgery in itself prolonged LOHS, and
recovery took longer in patients with at least one
comorbid disease than in healthy patients. In the
present study, there were 50 (25.6%) surviving
patients who had a delay before surgery, with a
mean delay of 40.7 ± 48.6 hours (range, 3–192
hours). The majority of postoperative complica-
tions (morbidity) from several previous stud-
ies5,15,16 were included as postoperative factors
in our final model. The postoperative factors with
statistical significance in model 2, except for non-
infective general complications, were the major
predictors of longer LOHS in patients who sur-
vived surgery for PPU. Hence, postoperative mor-
bidity in PPU was possibly related to longer
LOHS in surviving patients. One previous study
found that mean creatinine value (2.5 mg/dL) 
in patients who died is significantly different to
that in survivors (1.68 mg/dL), using logistic re-
gression analysis.6 In the present study, the dif-
ference in creatinine between survivors was too
small to influence LOHS in the final model, espe-
cially after adjustment for other factors. Although
preoperative shock was significantly associated
with mortality in previous studies,8–10,13,15,16 the
number of patients in the present study with pre-
operative shock in the final model was too small
to reveal any difference in LOHS. Moreover, shock
may be a sign of any infection or other complica-
tions. Hence, preoperative shock was not a signif-
icant factor in the final model after adjustment
for postoperative infections and complications.
Noninfective general complication was the only
postoperative factor that was significant in model
2 but did not significantly prolong LOHS in the
final model. A previous study showed that it was
not significantly related to mortality.13 According
to the predictive factors in the final model, LOHS
in patients who survive surgery for PPU can be
shortened by: (1) prevention of avoidable post-
operative infections such as catheter infection,
wound infection and cellulitis; (2) prevention 
of avoidable postoperative complications such
as wound dehiscence, anastomotic leakage, and
enterocutaneous fistula; (3) control of postoper-
ative infections such as bacteremia and pneumo-
nia; and (4) early surgery.
In conclusion, the potential limitations of this
retrospective study were the relatively small num-
ber of some variables, different discharge criteria
among healthcare institutions, and other non-
included risk factors such as American Society of
Anesthesiologists scores, size of ulcer, and amount
of abdominal fluid. There were also many con-
founders that we did not consider, such as the
type and duration of antibiotic treatment for in-
fection, the duration of mechanical ventilation
and intensive care, and health insurance prob-
lems. It was probably not possible to analyze
these factors because of the amount of data not
obtainable using a retrospective design. These lim-
itations might affect our predictive model and
the results of our analyses. Therefore, it is neces-
sary to establish a prospective study with a large
number of observations for further study. To the
authors’ knowledge, this is the first study to focus
on survivors of surgery for PPU and to construct
a predictive model for LOHS in these patients.
Catheter infection, pneumonia, UTI, wound in-
fection, noninfective abdominal complications,
bacteremia, other infections, delay before surgery
of > 12 hours, and comorbidity were associated
independently with longer LOHS. A predictive
model established with these variables explained
71.6% of the variation in LOHS among post-
operative survivors with PPU. Some corrective
methods or modifiable factors based on these
factors may be devised.
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